[Hypoxic pulmonary vasoconstriction and angiotensin II blockade in calves (author's transl)]. 1979

L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini

The pulmonary vascular response to breathing low oxygen containing gas mixture was examined before and during Angiotensin II blockade in five open-chested newborn calves. Angiotensin II blockade was achieved by continuous infusion of Sar1-Ile5-Leu8-Angiotensin II (Saralasin), a competitive inhibitor of Angiotensin II. The hypoxic rise in pulmonary vascular resistance after blockade did not differ from that of control. It is concluded that Angiotensin II does not play a significant role in acute hypoxic pulmonary vasoconstriction in the calf.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions

Related Publications

L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
September 1996, Chest,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
December 1995, Cardiovascular research,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
August 1979, Kokyu to junkan. Respiration & circulation,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
January 2008, Neonatology,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
August 2004, Critical care (London, England),
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
February 1986, Wiener klinische Wochenschrift,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
January 1990, Lung,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
July 1977, Klinische Wochenschrift,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
March 1979, Nihon Kyobu Shikkan Gakkai zasshi,
L Mattioli, and R M Zakheim, and M Toyama, and M K Park, and A Molteni, and T Vaseenon, and G L Nicolosi, and D Zanuttini
January 1980, Bulletin europeen de physiopathologie respiratoire,
Copied contents to your clipboard!